New directions with hormone therapy in prostate cancer: possible benefit from blocking prolactin and use of hormone treatment intermittently in combination with immunotherapy

This publication has 10 references indexed in Scilit:

• Castration-Induced Lymphocytosis in Prostate Cancer: Possible Evidence for Gonad/Thymus Endocrine Interaction in Man
  Urologia Internationalis, 1995
• Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen
  Cancer, 1993
• Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume
  Cancer, 1993
• Topical BCG for recurrent superficial bladder cancer
  The Lancet, 1991
• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989
• Clinical Follow-Up of Prostatic Cancer Patients under Intermittent Treatment with Fosfestrol and Bromocriptine
  Urologia Internationalis, 1988
• Interactions Between the Gonadal Steroids and the Immune System
  Science, 1985
• High Serum Prolactin Associated with Poor Prognosis in Carcinoma of the Prostate
  British Journal of Urology, 1984
• The effect of condom use on squamous cell cervical intraepithelial neoplasia
  American Journal of Obstetrics and Gynecology, 1981
• SPERM BASIC PROTEINS IN CERVICAL CARCINOGENESIS: CORRELATION WITH SOCIOECONOMIC CLASS
  The Lancet, 1978